THC + CBD and Memory Study
Launched by HARTFORD HOSPITAL · Apr 19, 2021
Trial Information
Current as of June 06, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The THC + CBD and Memory Study is designed to explore how using marijuana, specifically its active ingredients THC and CBD, affects memory. Researchers want to understand if CBD can help reduce memory problems caused by THC, the main psychoactive component of marijuana. To do this, they will use brain imaging (MRI) and various memory tests to assess how these substances impact thinking and memory skills.
The study is looking for right-handed individuals aged 65 to 74 who have used marijuana at least once in the past year but not more than once a month. Participants should be in good health and able to understand English well enough to follow the study instructions. It’s important to note that individuals who use certain medications, have a history of substance dependence, or have specific health conditions may not be eligible. If you join this study, you can expect to undergo memory testing and an MRI scan to help researchers learn more about how THC and CBD affect memory.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Right-handed
- • Prior MJ users (has used MJ at least once in the past year, but no more than 1x/month in the past 12 months)
- • Medically healthy (as determined by medical history and treatment)
- • Adequate comprehension of English in order to complete study materials
- • Acceptable birth control method for women (i.e., no copper IUD or any device that is not MRI safe)
- Exclusion Criteria:
- • Participant currently uses psychoactive medications or substances
- • Psychiatric diagnoses (determined by DSM-V)
- • Participant heavily or regularly uses MJ (more than 1x/month in the past year)
- • Current or past substance dependence (including MJ)
- • Positive urine toxicology screens
- • Positive pregnancy screens
- • MRI contraindications (e.g., heart pacemaker)
About Hartford Hospital
Hartford Hospital is a leading academic medical center affiliated with the University of Connecticut, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical research, the hospital focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and enhance treatment methodologies. With a robust infrastructure and a multidisciplinary team of experts, Hartford Hospital fosters a collaborative environment that supports the development and implementation of cutting-edge medical interventions, ultimately contributing to the advancement of medical science and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Godfrey Pearlson, MD
Principal Investigator
Hartford Hospital - Olin Neuropsychiatry Research Center; Yale University
Alecia Dager, PhD
Principal Investigator
Hartford Hospital - Olin Neuropsychiatry Research Center; Yale University
Michael Stevens, PhD
Principal Investigator
Hartford Hospital - Olin Neuropsychiatry Research Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials